Migdal Insurance & Financial Holdings’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3
Closed 500
2024
Q4
$0 Sell
3
-15
-83% -$145 ﹤0.01% 505
2024
Q3
$0 Sell
18
-180
-91% -$1.55K ﹤0.01% 534
2024
Q2
$2K Hold
198
﹤0.01% 500
2024
Q1
$2K Buy
198
+76
+62% +$669 ﹤0.01% 364
2023
Q4
$1K Sell
122
-7
-5% -$65 ﹤0.01% 470
2023
Q3
$1K Hold
129
﹤0.01% 479
2023
Q2
$1K Sell
129
-187
-59% -$1.66K ﹤0.01% 495
2023
Q1
$3K Buy
316
+114
+56% +$1.26K ﹤0.01% 494
2022
Q4
$2K Hold
202
﹤0.01% 508
2022
Q3
$2K Sell
202
-7
-3% -$85 ﹤0.01% 504
2022
Q2
$2K Buy
+209
New +$2.31K ﹤0.01% 599

Other funds holding ENFN

Migdal Insurance & Financial Holdings's ENFN Position: Q1 2025 in Review

Migdal Insurance & Financial Holdings sold out of Enfusion, Inc. (ENFN) in Q1 2025, closing a stake of 3 shares.

Migdal Insurance & Financial Holdings first reported a position in ENFN in Q2 2022 and held it in 11 quarters. The position peaked at $3K in Q1 2023. 132 funds tracked by Wall St. Rank hold ENFN as of Q1 2025.

  • Migdal Insurance & Financial Holdings reported no remaining Enfusion, Inc. position as of Q1 2025 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 3 Enfusion, Inc. shares in Q1 2025.
  • Migdal Insurance & Financial Holdings first reported a position in Enfusion, Inc. in Q2 2022 and held it in 11 quarters.
  • Migdal Insurance & Financial Holdings's Enfusion, Inc. position peaked at $3K in Q1 2023.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2025.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q1 2025, filed 5 May 2025.